Talkiatry Connect
Referral partnership program for health systems and clinicians
Company profile
Company profile
Talkiatry is a national virtual psychiatry practice that provides accessible, in-network mental health care through a network of employed clinicians. Founded by a patient who couldn't access needed care and a provider frustrated by system limitations, the company reimagined psychiatric care delivery to address critical access gaps. Talkiatry employs over 800 psychiatrists and psychiatric nurse practitioners, plus 300+ therapists, who provide comprehensive mental health services entirely online. The practice treats a wide range of conditions including ADHD, anxiety disorders, depression, bipolar disorder, OCD, PTSD, substance use disorders, insomnia, and peripartum/postpartum mental health issues. Patients can be matched with clinicians in minutes and typically see a provider within days rather than the months-long waits common in traditional psychiatry. All clinicians are in-network with major insurance providers, making care affordable with most patients paying around $30 per visit. The company partners with nearly a third of the top 20 U.S. health systems to expand behavioral health access for their patient populations at no cost to the health systems. Talkiatry's model emphasizes continuity of care, with patients working with the same psychiatrist over time, supported by longer appointment times that allow for relationship building. The practice operates across 46+ states and serves both adult and pediatric populations (ages 5-18). Clinical outcomes data shows 78% of patients experience symptom reduction and 65% achieve remission of clinically significant symptoms after five visits.
Company description Talkiatry official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Expanded to 46+ states, grew to 800+ psychiatrists/PMHNPs and 300+ therapists, completed 3,000,000+ visits, achieved 13,000+ 5-star reviews, partnered with nearly one-third of Top 20 U.S. Health Systems
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Referral partnership program for health systems and clinicians
100% online, in-network psychiatry with appointments in days
Licensed therapists for talk therapy and counseling
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
JMIR formative research · Sep 26, 2025
Professional Development Program for New Psychiatry Graduates in an Outpatient Telepsychiatry Practice.The Journal of continuing education in the health professions · Apr 1, 2025
Area Deprivation Index and Coprescription of Opioids and Sedative Hypnotics.Cureus · Mar 1, 2025
Developmental milestones and daily living skills in individuals with Angelman syndrome.Journal of neurodevelopmental disorders · Jun 15, 2024
Trauma Exposure in Migrant Children: Impact on Sleep and Acute Treatment Interventions.Child and adolescent psychiatric clinics of North America · Apr 1, 2024
Cultural Considerations and Response to Trauma for Displaced Children at the Border.Child and adolescent psychiatric clinics of North America · Apr 1, 2024
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Patients with anxiety and depression
After 5 visits, defined as GAD-7/PHQ-8 score less than 10
After 5 visits
Based on PHQ-8 or GAD-7 responses from 1/24-9/25
Talkiatry patients vs. comparison group per national insurer analysis
Talkiatry patients vs. comparison group
Per national insurer cohort analysis
Treating anxiety and depression through telepsychiatry
78% reduction in symptoms, 65% no clinically significant symptoms, 28% clinical remission after 5 visits; 86% feel better after 2 visits
Reducing hospitalizations and ER visits for behavioral health patients through virtual psychiatry access
68% fewer hospitalizations, 32% fewer ER visits, $700 savings per member per month
Expanding in-network psychiatry access for ambulatory and outpatient populations with fast appointments and no administrative burden
35% of top U.S. health systems partner with Talkiatry; nearly a third of Top 20 Health Systems in America use the platform
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Talkiatry's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.